BiotechTube
Polymun Scientific

Polymun Scientific

Klosterneuburg, Austria· Est.
polymun.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $800K

Overview

Polymun Scientific is a privately held, revenue-generating CDMO based in Klosterneuburg, Austria, with a 30+ year history in bioprocessing and liposome technology. The company operates a dual business model, providing contract services for client molecules while advancing its own pipeline of preclinical biopharmaceutical and formulation projects, including an HIV antibody program. Its core strengths lie in its established manufacturing capabilities for complex biologics and its specialized knowledge in liposomal/LNP delivery systems, positioning it in the growing market for advanced therapeutics and vaccine delivery.

Infectious DiseaseInflammatory DiseasesHematologic Disorders

Technology Platform

Integrated platform for biopharmaceutical process development (gene to GMP) and specialized liposomal/lipid nanoparticle (LNP) formulation technology for targeted drug delivery.

Funding History

1
Total raised:$800K
Grant$800K

Opportunities

High demand for LNP expertise driven by mRNA vaccine/therapy growth provides a major service opportunity.
The company's internal pipeline, particularly in HIV, offers potential for future value creation through partnerships or asset licensing.
Its EU-based, integrated CDMO services cater to a strong regional biotech sector.

Risk Factors

Faces intense competition from larger global CDMOs and risks client concentration.
Proprietary R&D programs are preclinical and carry high technical and regulatory failure risk.
The business is dependent on maintaining cutting-edge technological capabilities and stringent regulatory compliance.

Competitive Landscape

Operates in a crowded global CDMO market competing against large players like Lonza, Catalent, and Samsung Biologics, as well as specialized lipid nanoparticle firms. Differentiation is based on niche expertise in liposomal/LNP formulation, integrated services from gene to GMP, and a long track record in antibody and infectious disease biologics.

More companies in Biologics / Biosimilars →More companies in Austria →